Bone mineral density in postmenopausal women with diabetes mellitus 2
Keywords:
bone mineral density, osteoporosis, ostmenopausal, diabetes mellitusAbstract
Introduction: osteoporosis is a global health problem, its importance increases with population aging. Decreased bone mineral density is directly related to advanced age and the presence of clinical risk factors such as diabetes mellitus and postmenopause.Objective: to describe bone mineral density and its association with age and clinical characteristics of diabetes mellitus 2 in postmenopausal women.
Methods: a descriptive, cross-sectional research was conducted in 119 postmenopausal women, with and without diabetes mellitus, who were seen at the Endocrinology Consultation of the “Arnaldo Milián Castro” Hospital, in the period from January 2018 to September 2019, and selected by non-probabilistic purposive sampling.
Results: among women with diabetes osteoporosis was more frequent in the lumbar spine (66.1%), followed by osteopenia (21%) and normal bone mineral density (13%). At the hip level 39% had osteopenia, 35.5% osteoporosis and 29% normal bone mineral density. There was a significant statistical association of decreased bone mineral density in the lumbar spine with poor metabolic control (p=0.05), diabetes mellitus complications (p=0.030) and metformin treatment (p=0.027).
Conclusions: in the postmenopausal women with diabetes studied, compared to women without diabetes, bone mineral density decreased with increasing age. At the lumbar spine level, the presence of osteopenia and osteoporosis was associated with poor metabolic control, treatment with metformin and the presence of chronic complications of diabetes.
Downloads
References
1.World Health Organization. Assessment of fracture risk and its application to screening for postmenopausal osteoporosis: report of a WHO study group [meeting held in Rome from 22 to 25 June 1992] [Internet]. Ginebra: WHO; 1994 [citado 12/12/2022]. Disponible en: https://apps.who.int/iris/handle/10665/39142
2.Jiménez M, Henríquez C, Miranda F, Olmedo M, Ivanovic-Zuvic D, Florenzano P. Osteoporosis postmenopáusica: relevancia de la búsqueda estructurada de causas secundarias. Rev Méd Chile [Internet]. 2022 [citado 12/12/2022];150(5):597-602. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872022000500597. http://dx.doi.org/10.4067/s0034-98872022000500597
3.Pacheco Pantoja EL, Salazar Ciau P, Yáñez Pérez V. Metabolismo óseo y osteoporosis: conceptos y funciones. Rev Bioméd [Internet]. 2022 [citado 12/12/2022];33(1):22-32. Disponible en: https://www.revistabiomedica.mx/index.php/revbiomed/article/view/906/987. https://doi.org/10.32776/revbiomed.v33i1.906
4.Muñoz Torres M, Carazo Gallego A, Jiménez López JC, Avilés Pérez MD, Díaz Arco S, Lozano Alonso S, et al. Entorno inflamatorio diferencial en pacientes con osteoporosis y diabetes mellitus tipo 2. Rev Osteoporos Metab Miner [Internet]. 2022 [citado 12/12/2022];14(1):34-41. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2022000100004. https://dx.doi.org/10.4321/S1889-836X2022000100004
5.Nuti R, Brandi ML, Checchia G, Di Munno O, Dominguez L, Falaschi P, et al. Guidelines for the management of osteoporosis and fragility fractures. Intern Emerg Med [Internet]. 2019 [citado 12/12/2022];14(1):85-102. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6329834/. https://doi.org/10.1007/s11739-018-1874-2
6.Riancho JA, Peris P, González Macías J, Pérez Castrillón JL, Comisión de Redacción de las Guías de Osteoporosis de la SEIOMM. Guías de práctica clínica en la osteoporosis postmenopáusica, glucocorticoidea y del varón (actualización 2022). Rev Osteoporos Metab Miner [Internet]. 2022 [citado 12/12/2022];14(1):13-33. Disponible en: https://scielo.isciii.es/pdf/romm/v14n1/1889-836X-romm-14-01-13.pdf. https://dx.doi.org/10.4321/s1889-836x2022000100003
7.Campillo-Sánchez F, Usategui-Martin R, Gil J, Ruiz de Temiño A, González-Silva Y, Ruiz-Mambrilla M, et al. Predictores del riesgo de fractura en una población de mujeres postmenopáusicas mediante el procedimiento estadístico binario CART. Rev Osteoporos Metab Miner [Internet]. 2020 [citado 12/12/2022];12(4):122-128. Disponible en: https://scielo.isciii.es/scielo.php?script=sci_arttext&pid=S1889-836X2020000400003. https://dx.doi.org/10.4321/s1889-836x2020000400003
8.Fernández Morales A, Vargas Dutra AC, Romariz C, Souto R, Calegari M, Palleiro D. Utilidad del Trabecular Bone Score combinado con la densitometría ósea en la valoración de una serie 194 pacientes. Rev Méd Urug [Internet]. 2022 [citado 12/12/2022];38(1):e38105. Disponible en: http://www.scielo.edu.uy/pdf/rmu/v38n1/1688-0390-rmu-38-01-e204.pdf. https://doi.org/10.29193/RMU.38.1.4
9.Sosa Henríquez M, Gómez de Tejada Romero MJ. Historia de Revista de Osteoporosis y Metabolismo Mineral. Su situación diez años después. Rev Osteoporos Metab Miner [Internet]. 2018 [citado 23/04/2019];10(1):3-6. Disponible en: https://scielo.isciii.es/pdf/romm/v10n1/2173-2345-romm-10-01-3.pdf. http://dx.doi.org/10.4321/S1889-836X2018000100001
10.Díaz Socorro C, Navarro Despaigne D, Santana Pérez F, Domínguez Alonso E, Bacallao Gallestey J. Factores de riesgo modificables o no, relacionados con la densidad mineral ósea en mujeres de edad mediana. Rev Cubana Endocrinol [Internet]. 2012 [citado 23/04/2019];23(1):44-55. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532012000100004
11.Chelala Friman CR, Zaldívar Campos A, Bruzón Cabrera LC. Factores de riesgo y la prevención de la osteoporosis. CCM [Internet]. 2017 [citado 25/02/2020];21(4):1174-1184. Disponible en: https://revcocmed.sld.cu/index.php/cocmed/article/view/2205/1186
12.Guerra JR, Urdaneta JR, Villalobos N, Contreras Benítez A, García J, Baabel NS, et al. Factores de riesgo para alteraciones de la densidad mineral ósea en mujeres posmenopáusicas. Rev Chil Obstet Ginecol [Internet]. 2015 [citado 15/02/2019];80(5):385-393. Disponible en: https://scielo.conicyt.cl/scielo.php?script=sci_arttext&pid=S0717-75262015000500006. http://dx.doi.org/10.4067/S0717-75262015000500006
13.Pérez Rojas JM, Maroto Fernandez KE. Osteoporosis Primaria: Estratificación del Riesgo de Fractura en la Atención Primaria. Med Leg Costa Rica [Internet]. 2018 [cidado 21/09/2021];35(1):84-93. Disponible en: https://www.scielo.sa.cr/scielo.php?script=sci_arttext&pid=S1409-00152018000100084
14.Díaz Rizo V, Guzmán Aguayo AK, Araujo Guirado V, Ramírez Villafaña M, Nava Zavala AH, Gámez Nava JI, et al. Factores nutricionales relacionados con osteoporosis. El Residente [Internet]. 2018 [citado 26/11/2019];13(1):23-30. Disponible en: https://www.medigraphic.com/pdfs/residente/rr-2018/rr181d.pdf
15.Sánchez Delgado JA, Sánchez Lara NE. Epidemiología de la diabetes mellitus tipo 2 y sus complicaciones. Rev Finlay [Internet]. 2022 [citado 25/02/2023];12(2):168-176. Disponible en: https://revfinlay.sld.cu/index.php/finlay/article/view/1121/2114
16.Romero-Díaz C, Duarte-Montero D, Gutiérrez-Romero SA, Mendivil CO. Diabetes and Bone Fragility. Diabetes Ther [Internet]. 2021[citado 25/02/2023];12(1):71-86. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7843783/. https://doi.org/10.1007/s13300-020-00964-1
17.Hayón Ponce M, García Fontana B, Avilés Pérez MD, González Salvatierra S, Moratalla Aranda E, Muñoz Torres M. Fuerza muscular como predictora de fragilidad ósea en pacientes con diabetes mellitus tipo 2. Rev Osteoporos Metab Miner [Internet]. 2021 [citado 25/02/2023];13(4):137-144. Disponible en: https://scielo.isciii.es/pdf/romm/v13n4/1889-836X-romm-13-4-0137.pdf. http://dx.doi.org/10.4321/S1889-836X2021000300006
18.Valencia Chión F, Correa López LE, Huarachi Morales L, Huamán Guerrero MO, De La Cruz Vargas JA. Diabetes mellitus tipo 2 asociado a osteoporosis en pacientes postmenopáusicas del Hospital Nacional Hipólito Unanue en el período 2014-2016. Rev Fac Med Hum [Internet]. 2016 [citado 25/02/2023];16(3):46-52. Disponible en: https://revistas.urp.edu.pe/index.php/RFMH/article/view/652. https://doi.org/10.25176/RFMH.v16.n3.652
19.Rizzoli R. Postmenopausal osteoporosis: Assessment and management. Best Pract Res Clin Endocrinol Metab [Internet]. 2018 [citado 25/02/2023];32(5):739-757. Disponible en: https://pubmed.ncbi.nlm.nih.gov/30449552/. https://doi.org/10.1016/j.beem.2018.09.005
20.Kanis JA, Cooper C, Rizzoli R, Reginster JY. European guidance for the diagnosis and management of osteoporosis in postmenopausal women. Osteoporos Int [Internet]. 2019 [citado 25/02/2023];30(1):3–44. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7026233/. https://doi.org/10.1007/s00198-018-4704-5
21.Torres Jiménez AP, Torres Ricón JM. Climaterio y menopausia. Rev Fac Med (Méx) [Internet]. 2018 [citado 18/09/2019];61(2):51-58. Disponible en: https://www.scielo.org.mx/pdf/facmed/v61n2/2448-4865-facmed-61-02-51.pdf
22.Garrido F, Arraztoa JA. El desafío clínico en el manejo de las pacientes climatéricas. Rev Chil Obstet Ginecol [Internet]. 2018 [citado 20/01/2019];83(5):442-443. Disponible en: https://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0717-75262018000500442. http://dx.doi.org/10.4067/s0717-75262018000500442
23.Slaidina A, Nikitina E, Abeltins A, Soboleva U, Lejnieks A. Gray values of the cervical vertebrae detected by cone beam computed tomography for the identification of osteoporosis and osteopenia in postmenopausal women. Oral Surg Oral Med Oral Pathol Oral Radiol [Internet]. 2022 [citado 12/12/2022];133(1):100-109. Disponible en: https://pubmed.ncbi.nlm.nih.gov/34535433/. https://doi.org/10.1016/j.oooo.2021.06.014
24.Jordán Padrón M, Blanco Pereira ME, Saavedra Jordán M, Valenzuela Cordero E, Valenzuela Cordero A. Osteoporosis, un problema de salud de estos tiempos. Rev Méd Electrón [Internet]. 2021 [citado 19/11/2021];43(2):478-487. Disponible en: https://www.revmedicaelectronica.sld.cu/index.php/rme/article/view/4014/5077
25.Medina Orjuela A, Rosero Olarte O, Rueda Plata PN, Sánchez Escobar F, Chalem Choueka M, González Reyes MA, et al. II Consenso Colombiano para el Manejo de la Osteoporosis Posmenopáusica. Rev Colomb Reumatol [Internet]. 2018 [citado 19/11/2021];25(3):184–210. Disponible en: http://www.scielo.org.co/pdf/rcre/v25n3/0121-8123-rcre-25-03-184.pdf
26.Montagner Rossi LM, Martínez Copes R, Canterle Dal Osto L, Flores C, Vasconcellos Comim F, Orlandin Premaor M. Factors related with osteoporosis treatment in postmenopausal women. Medicine [Internet]. 2018 [citado 19/11/2021];97(28):e11524. Disponible en: https://journals.lww.com/md-journal/fulltext/2018/07130/factors_related_with_osteoporosis_treatment_in.73.aspx. https://doi.org/10.1097/MD.0000000000011524
27.Sauque Reyna L, Salcedo Parra MA, Sánchez Vargas PR, Flores Helguera JD, Badillo Sánchez C, Reza Albarrán A, et al. Densidad mineral ósea en pacientes con diabetes tipo 2. Rev Investig Clín [Internet]. 2011 [citado 19/11/2021];63(2):162-169. Disponible en: https://www.medigraphic.com/pdfs/revinvcli/nn-2011/nn112h.pdf
28.Gauthier A, Kanis JA, JiangY, Martin M, Compston JE, Borgström F, et al. Epidemiological burden of postmenopausal osteoporosis in the UK from 2010 to 2021: estimations from a disease model. Arch Osteoporos [Internet]. 2011 [citado 19/11/2021];6:179-188. Disponible en: https://pubmed.ncbi.nlm.nih.gov/22886104/. https://doi.org/10.1007/s11657-011-0063-y
29.Crandall CJ, Vasan S, LaCroix A, LeBoff MS, Cauley JA, Robbins JA, et al. Bone Turnover Markers Are Not Associated With Hip Fracture Risk: A Case-Control Study in the Women’s Health Initiative. J Bone Miner Res [Internet]. 2018 [citado 19/11/2021];33(7):1199-1208. Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7060935/. https://doi.org/10.1002/jbmr.3471
30.Castro Gamboa A, Chaves Castillo M, González González E, Arce Corrales LP, Solís Barquero SM. Factores de riesgo y prevalencia de osteopeniay osteoporosis en mujeres posmenopáusicas diagnosticadas por densitometría ósea. Acta Méd Costarric [Internet]. 2022 [citado 12/12/2022];64(1):44-51. Disponible en: https://www.scielo.sa.cr/pdf/amc/v64n1/0001-6002-amc-64-01-44.pdf. https://doi.org/10.51481/amc.v64i1.1217
31.Reyes García R, Rozas Moreno P, Muñoz Torres M. Enfermedad cardiovascular, diabetes mellitus tipo 2 y osteoporosis. Rev Osteoporos Metab Miner [Internet]. 2010 [citado 12/11/2019];2(2):47-54. Disponible en: https://www.redalyc.org/pdf/3609/360933650007.pdf
32.Acosta Cedeño A, Navarro Despaigne D, Díaz Socorro C, Álvarez Y, Domínguez Alonso E, González Calero T, et al. Calidad del hueso en mujeres de edad mediana con diabetes mellitus tipo 2. Rev Cubana Endocrinol [Internet]. 2008 [citado 23/04/2019];19(1):[aprox. 5 p.]. Disponible en: http://scielo.sld.cu/scielo.php?script=sci_arttext&pid=S1561-29532008000100005
33.Vestergaard P, Rejnmark L, Mosekilde L. Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes. Calcif Tissue Int [Internet]. 2009 [citado 23/04/2019];84(1):45-55. Disponible en: https://pubmed.ncbi.nlm.nih.gov/19067021/. https://doi.org/10.1007/s00223-008-9195-5
34.Quevedo I, Hameau R, Arroyo C. Efecto del tratamiento prolongado con metformina sobre la densidad mineral ósea en las mujeres postmenopáusicas con diabetes tipo 2. Rev Chil Endocrinol Diabetes [Internet]. 2015 [citado 23/04/2019];8(4):162-166. Disponible en: https://revistasoched.cl/4_2015/4.pdf
35.Rozas Moreno P, Reyes García R, Jódar Gimeno E, Varsavsky M, Luque Fernández I, Cortés Berdonces M, et al. Recomendaciones sobre el efecto de los fármacos antidiabéticos en el hueso. Endocrinol Diabetes Nutr [Internet]. 2017 [citado 23/04/2019];64(S1):1-6. Disponible en: https://www.elsevier.es/es-revista-endocrinologia-diabetes-nutricion-13-pdf-S2530016416300064
36.Borges JLC, Bilezikian JP, Jones-Leone AR, Acusta AP, Ambery PD, Nino AJ, et al. A randomized, parallel group, double-blind, multicenter study comparing the efficacy and safety of Avandamet (rosiglitazone/metformin) and metformin on long-term glycaemic control and bone mineral density after 80 weeks of treatment in drug-naïve type 2 diabetes mellitus patients. Diabetes Obes Metab [Internet]. 2011 [citado 23/04/2019];13(11):1036-46. Disponible en: https://pubmed.ncbi.nlm.nih.gov/21682834/. https://doi.org/10.1111/j.1463-1326.2011.01461.x
Downloads
Published
How to Cite
Issue
Section
License
Authors who have publications with this journal agree to the following terms:
- Authors will retain their copyright and assign to the journal the right of first publication of their work, which will simultaneously be subject to a Creative Commons License / Attribution-Noncommercial 4.0 International (CC BY-NC 4.0) that allows third parties to share the work as long as its author and first publication in this journal are indicated.
- Authors may adopt other non-exclusive license agreements for distribution of the published version of the work (e.g., depositing it in an institutional repository or publishing it in a monographic volume) as long as the initial publication in this journal is indicated.
- Authors are allowed and encouraged to disseminate their work through the Internet (e.g., in institutional telematic archives or on their web page) before and during the submission process, which can produce interesting exchanges and increase citations of the published work. (See The effect of open access).
15 junio 2025
